Allinaire Therapeutics, LLC
CLEVELAND, OH · Founded 2015 · CIK 0001676987 · Biotech · Private
Humanized monoclonal antibody (mAb) targeting EMAP II for emphysematous COPD treatment
allinaire.com →- Grants
- $3.0M
- 4 awards
- Sector median: 1
- Raised
- $950K
- 1 Form D · Dec 2016
- 118 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $950,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Fully Humanized Antibody for Treating Lung Emphysema | $52,013 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Fully Humanized Antibody for Treating Lung Emphysema | $1,673,916 | |
| Federal grant | Department of Health and Human Services · Phase I · Humanized EMAP II mAb as a Novel Therapy for Viral-Associated Lung Injury | $281,155 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Fully Humanized Antibody for Treating Lung Emphysema | $958,776 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2358 | NEW EQUILIBRIUM BIOSCIENCES, INC. | — | $10M |
| 2359 | Metalytics, LLC | — | — |
| 2360 | OLIGOMERIX INC | — | $2.9M |
| 2361 | Allinaire Therapeutics, LLC | — | $950K |
| 2362 | ECM Therapeutics, Inc. | — | $919K |
| 2363 | ACRIGEN BIOSCIENCES, INC. | — | $775K |
| 2364 | MARCH BIOSCIENCES INC | — | $22M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Baiju ShahDirector · Executive Officer
- Brian StemmeDirector
- Ted TorphyDirector
Patents
- Humanized Anti-emap II Therapeutic Antibodiesapplication
- Humanized Anti-emap II Therapeutic Antibodiesapplication
- Humanized Anti-EMAP II Therapeutic Antibodiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.